It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neoplasms of the lungs are the leading cause of cancer incidence and mortality worldwide. Although immunotherapy has increased the overall survival of patients with lung cancer, there is the need to improve this treatment. At this regard, blood lipid levels are thought to be linked to cancer risk and thus a preventive intervention through regulation of the nutrition of patients with lung cancer is gaining much attention. In this study, we therefore asked about the contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression. We measured different serum lipids and analyzed cholesterol synthesis enzymes 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) and acetyl-coenzyme A cholesterol acetyltransferase 1 (ACAT1) as well as the cholesterol cellular export protein ATP-binding cassette (ABC) A-1 mRNA by quantitative PCR (qPCR) in the control and tumoral regions of post-surgery lung tissues to analyze the accumulation of cholesterol in cancer cells in a cohort of patients with lung adenocarcinoma (LUAD). We found that triglycerides in serum directly correlated with the body mass index (BMI) in patients with LUAD. By contrast, we found that high-density lipoprotein (HDL) cholesterol inversely correlated with the BMI, C-reactive protein (CRP) and overall survival and total cholesterol inversely correlated with the tumor diameter, serum CRP and overall survival in these LUAD patients. Functionally, the role of cholesterol is indispensable for the growth and development of normal animal cells where it is tightly regulated. Excess of cellular cholesterol regulated by HMGCR is converted to cholesteryl esters by the enzyme ACAT1 and exported extracellularly by the cholesterol transporter ABCA1. Here we found HMGCR and ACAT1 upregulated and ABCA1 downregulated in the lung’s tumoral region of our LUAD cohort, indicating cholesterol dysregulated cellular export in lung tumor cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Department of Molecular Pneumology, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525)
2 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Department of Thoracic Surgery, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525)
3 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Institute of Pathology, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525)
4 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Laboratory of Clinic Medicine, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525)
5 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Department of Thoracic Surgery, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525); Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany (GRID:grid.512309.c) (ISNI:0000 0004 8340 0885)
6 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Institute of Pathology, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525); Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany (GRID:grid.512309.c) (ISNI:0000 0004 8340 0885)
7 Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Department of Molecular Pneumology, Erlangen, Germany (GRID:grid.411668.c) (ISNI:0000 0000 9935 6525); Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany (GRID:grid.512309.c) (ISNI:0000 0004 8340 0885); Friedrich-Alexander-Universität Erlangen-Nürnberg, Laboratories of Cellular and Molecular Lung Immunology, Department of Molecular Pneumology, Erlangen, Germany (GRID:grid.5330.5) (ISNI:0000 0001 2107 3311)